Overview:
A broad-spectrum antibiotic effective for various infections, ensuring enhanced bioavailability for better outcomes.
Third-generation cephalosporin
200-400 mg/day as a single dose or in 2 divided doses.
Respiratory tract infections.
Uncomplicated urinary tract infections.
Otitis media.
Pharyngitis and tonsillitis.
Sinusitis.
Bronchitis.
Typhoid fever.
Inhibits bacterial cell wall synthesis by disrupting peptidoglycan cross-linking, causing bacterial lysis.
